NYLIM
HRMY icon

New York Life Investment Management’s Harmony Biosciences HRMY Stock Holding History

New York Life Investment Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,136
Closed -$374K – 1070
2024
Q1 		$374K Buy
11,136
+478
+4% +$15.3K ﹤0.01% 902
2023
Q4 		$344K Sell
10,658
-247
-2% -$6.89K ﹤0.01% 1132
2023
Q3 		$357K Sell
10,905
-1,718
-14% -$59.6K ﹤0.01% 992
2023
Q2 		$444K Sell
12,623
-1,538
-11% -$53.1K ﹤0.01% 826
2023
Q1 		$462K Buy
+14,161
New +$645K 0.01% 1120

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

New York Life Investment Management's HRMY Position: Q2 2024 in Review

New York Life Investment Management sold out of Harmony Biosciences (HRMY) in Q2 2024, closing a stake of 11,136 shares — an estimated $374K sold.

New York Life Investment Management first reported a position in HRMY in Q1 2023 and held it in 5 quarters. The position peaked at $462K in Q1 2023. 219 funds tracked by Wall St. Rank hold HRMY as of Q2 2024.

  • New York Life Investment Management reported no remaining Harmony Biosciences position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 11,136 Harmony Biosciences shares in Q2 2024, an estimated $374K.
  • New York Life Investment Management first reported a position in Harmony Biosciences in Q1 2023 and held it in 5 quarters.
  • New York Life Investment Management's Harmony Biosciences position peaked at $462K in Q1 2023.
  • 219 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.